find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
298
Clinical Trials
Transplant
NA
Accepting Patients
nct/study# NCT03147742 / INCB18424-MA-GD-301
An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
Learn More
Transplant
Phase II
Accepting Patients
nct/study# NCT02918292 / 1502
Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)
Learn More
Transplant
NA
Accepting Patients
nct/study# N/A / PRO00006200
Pilot Study Analyzing Blood Samples for Steroid Responsiveness using F-DEX Binding Assay
Learn More
Transplant
Phase I
Accepting Patients
nct/study# NCT04220190 / RAPA-501-ALS
Phase I Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) for Amyotrophic Lateral Sclerosis
Learn More
Transplant
Phase I/II
Accepting Patients
nct/study# NCT04482699 / RAPA501ALLOCOVID19
RAPA-501-ALLO-COVID-19, PI: Dr. Donato, Title: Phase I/Phase II Trial of Allogeneic Hybrid TREG/Th2 Cell (RAPA-501-Allo) Therapy for Severe, Post-Intubation Stage 3 COVID-19 Disease
Learn More
Transplant
NA
Accepting Patients
nct/study# NCT01166009 / NMDP-HSCT-DATABASE
A Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.